MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Episodic ataxia type 2: a previously undescribed variant in the CACNA1A gene

    N. Chunga, K. Minks, P. Morrison (Rochester, USA)

    Objective: To describe a previously unreported variant in the CACNA1A gene in a patient with episodic ataxia type 2 (EA2) phenotype. Background: EA2 is the…
  • 2023 International Congress

    Impacts of mutations in Parkinson’s disease-related genes on telomere maintenance

    YH. Chen, CH. Lin, CK. Tseng (Taipei, Taiwan)

    Objective: To investigate the correlation between telomere length (TL) and Parkinson’s disease (PD), and whether the change in telomere biology participates in PD pathogenesis. Background:…
  • 2023 International Congress

    Two Distinctive Anatomic Location in Brain Tumor Patients with Secondary Parkinsonism Manifestation: A Serial Case Report

    Y. Diansari, S. Marisdina (Palembang, Indonesia)

    Objective: We reported  two interesting cases  report of brain tumor patients  with different anatomic  location presenting secondary parkinsonism Background: Movement disorders caused by brain tumors are rare. The literature…
  • 2023 International Congress

    Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest): Development and Pilot Study of a Questionnaire for Stigma in Patients with Idiopathic Parkinson’s Disease

    V. Stopic, S. Jost, JC. Baldermann, JN. Petry-Schmelzer, G. Fink, T. Dembek, H. Dafsari, J. Kessler, M. Barbe, A. Sauerbier (Cologne, Germany)

    Objective: This pilot study aimed to develop and test a stigma questionnaire specific to patients with Parkinson’s disease (PDStigmaQuest). Background: Stigma is significant in PD.…
  • 2023 International Congress

    Targeting autophagy to identify novel modulators of Parkinson’s disease using midbrain organoids

    J. Jarazo, I. Rosety, C. Serra-Almeida, R. Marques, C. Saraiva, R. Davis, J. Schwamborn (Esch-sur-Alzette, Luxembourg)

    Objective: Natural compound libraries are a great source of new chemical molecules that could restore the altered phenotypes in patient derived cells. The objective of…
  • 2023 International Congress

    A baseline study for the first year of a diverse Parkinson’s Disease interdisciplinary clinic

    V. Armengol, M. Sarno, M. Feldman, S. Marmol, A. Alfonso, G. Dumenigo, M. Garcia-Casals, S. Munzesheimer, A. Otto, TW. Siu, D. Shpiner (Miami, USA)

    Objective: To characterize patients at a new diverse, academic Parkinson’s Disease (PD) interdisciplinary clinic (IDC). Background: PD affects patients in nearly all spheres of life,…
  • 2023 International Congress

    Neurophysiological architecture of visual categorization in early Parkinson’s disease with minor hallucinations

    L. Perez-Carasol, S. Martinez-Horta, A. Horta-Barba, A. Puig-Davi, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)

    Objective: To explore the neurophysiological dynamics of visual categorization in Parkinson’s disease (PD) with minor hallucinations. Background: Different hypotheses have been proposed for visual hallucinations…
  • 2023 International Congress

    Epigenome-wide meta-analysis of sex-differential DNA methylation in Parkinson’s disease

    T. Yang, C. Li, Q. Wei, R. Ou, Y. Cheng, K. Liu, J. Lin, Y. Xiao, H. Shang (Chengdu, China)

    Objective: To comprehensively characterize the blood-based DNA methylation alterations related to sex in patients with Parkinson's disease (PD), shedding light on the underlying genes and…
  • 2023 International Congress

    Education level and the onset and severity of symptoms in Huntington’s disease

    SR. Zhang, YF. Cheng, XJ. Gu, KC. Liu, JY. Lin, TM. Yang, Y. Xiao, QR. Jiang, JX. Huang, QQ. Wei, RW. Ou, YB. Hou, LY. Zhang, CY. Li, JM. Burgunder, HF. Shang (Chengdu, China)

    Objective: The current study aimed to investigate the effect of educational level on the clinical characteristics of Chinese patients with Huntington’s disease (HD). Background: Education…
  • 2023 International Congress

    Relationship between bradykinesia and cognitive functions in patients with essential tremor

    G. Paparella, L. Angelini, R. Margiotta, A. Cannavacciuolo, D. Costa, D. Birreci, M. de Riggi, M. Passaretti, D. Alunni Fegatelli, A. Berardelli, M. Bologna (Pozzilli, Italy)

    Objective: To investigate the association between bradykinesia, i.e., movement slowness, as objectively assessed with kinematic analysis, and cognitive functions in ET. Background: Bradykinesia in essential…
  • « Previous Page
  • 1
  • …
  • 174
  • 175
  • 176
  • 177
  • 178
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley